These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 33627025)
21. Diagnostic and prognostic value of baseline FDG PET/CT skeletal textural features in diffuse large B cell lymphoma. Aide N; Talbot M; Fruchart C; Damaj G; Lasnon C Eur J Nucl Med Mol Imaging; 2018 May; 45(5):699-711. PubMed ID: 29214417 [TBL] [Abstract][Full Text] [Related]
22. Comparison of bone marrow biopsy and fluorodeoxyglucose-positron emission tomography for the assessment of bone marrow infiltration in children with Hodgkin's lymphoma. Arslantaş E; Ayçiçek A; Akıcı F; Özkara S; Yılmaz B; Özdemir N; Bayram C Nuklearmedizin; 2023 Feb; 62(1):20-26. PubMed ID: 36746148 [TBL] [Abstract][Full Text] [Related]
24. Diagnostic accuracy of pelvic magnetic resonance imaging for the assessment of bone marrow involvement in diffuse large B-cell lymphoma. Ke Q; Liao CC; Tan XH; Guo BP; Cen H; Li LQ PLoS One; 2021; 16(5):e0252226. PubMed ID: 34043683 [TBL] [Abstract][Full Text] [Related]
25. Can Positron Emission Tomography and Computed Tomography Be a Substitute for Bone Marrow Biopsy in Detection of Bone Marrow Involvement in Patients with Hodgkin's or Non-Hodgkin's Lymphoma? Çetin G; Çıkrıkçıoğlu MA; Özkan T; Karatoprak C; Ar MC; Eşkazan AE; Ayer M; Cerit A; Gözübenli K; Uysal BB; Erdem S; Ergül N; Tatar G; Çermik TF Turk J Haematol; 2015 Sep; 32(3):213-9. PubMed ID: 25912844 [TBL] [Abstract][Full Text] [Related]
26. Role of bone marrow biopsy in staging of patients with classical Hodgkin's lymphoma undergoing positron emission tomography/computed tomography. Puccini B; Nassi L; Minoia C; Volpetti S; Ciancia R; Riccomagno PC; Di Rocco A; Mulè A; Toldo C; Sassone MC; Guariglia R; Filì C; Finolezzi E; Falorio S; Zanon S; Furlan A; Doa G; Zaja F; Ann Hematol; 2017 Jul; 96(7):1147-1153. PubMed ID: 28451805 [TBL] [Abstract][Full Text] [Related]
27. Diagnostic performance of 18F-2-fluoro-2-deoxy-D-glucose PET/computerized tomography in identifying bone marrow infiltration in new patients with diffuse large B-cell lymphoma and Hodgkin lymphoma. Kandeel AA; Hussein M; Zidan L; Younis J; Edesa W; Alsayed Y Nucl Med Commun; 2020 Mar; 41(3):269-279. PubMed ID: 31895758 [TBL] [Abstract][Full Text] [Related]
28. Diagnostic value of baseline Faudemer J; Aide N; Gac AC; Damaj G; Vilque JP; Lasnon C Sci Rep; 2021 Dec; 11(1):23812. PubMed ID: 34893676 [TBL] [Abstract][Full Text] [Related]
29. PET/CT-based bone-marrow assessment shows potential in replacing routine bone-marrow biopsy in part of patients newly diagnosed with extranodal natural killer/T-cell lymphoma. Wang Y; Xie L; Tian R; Deng Y; Zhang W; Zou L; Zhang H; Liu J; Zhao S; Ding W; Liu W; Jiang M J Cancer Res Clin Oncol; 2019 Oct; 145(10):2529-2539. PubMed ID: 31485768 [TBL] [Abstract][Full Text] [Related]
30. Accuracy and prognostic impact of FDG PET/CT and biopsy in bone marrow assessment of follicular lymphoma at diagnosis: A Nation-Wide cohort study. Ródenas-Quiñonero I; Chen-Liang T; Martín-Santos T; Salar A; Fernández-González M; Celades C; Navarro JT; Martínez-Garcia AB; Andreu R; Balaguer A; Martin García-Sancho A; Baile M; López-Jiménez J; Marquet-Palomanes J; Teruel AI; Terol MJ; Benet C; Frutos L; Navarro JL; Uña J; Suarez M; Cortes M; Contreras J; Ruiz C; Tamayo P; Mucientes J; Sopena-Novales P; Reguilón-Gallego L; Sánchez-Blanco JJ; Pérez-Ceballos E; Jerez A; Ortuño FJ Cancer Med; 2023 Mar; 12(6):6536-6546. PubMed ID: 36373169 [TBL] [Abstract][Full Text] [Related]
31. Is it sufficient to evaluate bone marrow involvement in newly diagnosed lymphomas using Hao B; Zhao L; Luo NN; Ruan D; Pang YZ; Guo W; Fu H; Guo XY; Luo ZM; Wu J; Chen HJ; Wu H; Sun L BMC Cancer; 2018 Nov; 18(1):1192. PubMed ID: 30497426 [TBL] [Abstract][Full Text] [Related]
32. Bone marrow biopsy superiority over PET/CT in predicting progression-free survival in a homogeneously-treated cohort of diffuse large B-cell lymphoma. Chen-Liang TH; Martín-Santos T; Jerez A; Rodríguez-García G; Senent L; Martínez-Millán C; Muiña B; Orero M; Teruel A; Martín A; Gómez-Espuch J; Kennedy K; Benet C; Raya JM; Fernández-González M; de la Cruz F; Guinot M; Villegas C; Ballester I; Baile M; Moya M; López-Jiménez J; Frutos L; Navarro JL; Uña J; Fernández-López R; Igua C; Contreras J; Sánchez-Vañó R; Cozar MDP; Tamayo P; Mucientes J; Sánchez-Blanco JJ; Pérez-Ceballos E; Ortuño FJ Cancer Med; 2017 Nov; 6(11):2507-2514. PubMed ID: 28960797 [TBL] [Abstract][Full Text] [Related]
33. Opportunities and limitations of bone marrow biopsy and bone marrow FDG-PET in lymphoma. Adams HJ; Nievelstein RA; Kwee TC Blood Rev; 2015 Nov; 29(6):417-25. PubMed ID: 26113144 [TBL] [Abstract][Full Text] [Related]
34. The role of bone marrow biopsy and FDG-PET/CT in identifying bone marrow infiltration in the initial diagnosis of high grade non-Hodgkin B-cell lymphoma and Hodgkin lymphoma. Accuracy in a multicenter series of 372 patients. Chen-Liang TH; Martin-Santos T; Jerez A; Senent L; Orero MT; Remigia MJ; Muiña B; Romera M; Fernandez-Muñoz H; Raya JM; Fernandez-Gonzalez M; Lancharro A; Villegas C; Carlos Herrera J; Frutos L; Luis Navarro J; Uña J; Igua C; Sanchez-Vaño R; Cozar Mdel P; Contreras J; Sanchez-Blanco JJ; Perez-Ceballos E; Ortuño FJ Am J Hematol; 2015 Aug; 90(8):686-90. PubMed ID: 25925613 [TBL] [Abstract][Full Text] [Related]
35. Whole-body MRI, FDG-PET/CT, and bone marrow biopsy, for the assessment of bone marrow involvement in patients with newly diagnosed lymphoma. Albano D; Patti C; Lagalla R; Midiri M; Galia M J Magn Reson Imaging; 2017 Apr; 45(4):1082-1089. PubMed ID: 27603267 [TBL] [Abstract][Full Text] [Related]
36. Routine bone marrow biopsy has little or no therapeutic consequence for positron emission tomography/computed tomography-staged treatment-naive patients with Hodgkin lymphoma. El-Galaly TC; d'Amore F; Mylam KJ; de Nully Brown P; Bøgsted M; Bukh A; Specht L; Loft A; Iyer V; Hjorthaug K; Nielsen AL; Christiansen I; Madsen C; Johnsen HE; Hutchings M J Clin Oncol; 2012 Dec; 30(36):4508-14. PubMed ID: 23150698 [TBL] [Abstract][Full Text] [Related]
37. Detection of bone marrow involvement in newly diagnosed post-transplant lymphoproliferative disorder: (18)F-fluorodeoxyglucose positron emission tomography/computed tomography versus bone marrow biopsy. Gheysens O; Thielemans S; Morscio J; Boeckx N; Goffin KE; Deroose CM; Sagaert X; Wlodarska I; Verhoef G; Dierickx D; Tousseyn T Leuk Lymphoma; 2016 Oct; 57(10):2382-8. PubMed ID: 26854937 [TBL] [Abstract][Full Text] [Related]
39. The Diagnostic Accuracy of Bone Marrow Biopsy Versus PET/CT Scan in Identifying Bone Marrow Involvement in Diffuse Large B Cell Lymphoma Patients at a Cancer Hospital. Asif H; Zubair R; Siddiqui IA; Tariq Mahmood M; Jamil A; Tahir A Cureus; 2023 Feb; 15(2):e34901. PubMed ID: 36938170 [TBL] [Abstract][Full Text] [Related]
40. Prognostic significance of bone marrow infiltration detected by PET-CT in newly diagnosed diffuse large B cell lymphoma. Liang JH; Sun J; Wang L; Fan L; Chen YY; Qu XY; Li TN; Li JY; Xu W Oncotarget; 2016 Apr; 7(14):19072-80. PubMed ID: 26919239 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]